NVO
Novo Nordisk A/S
NVO (Novo Nordisk A/S) has a reliability-weighted signal score of 62/100 on StockMarketSignals, based on 3 finance YouTubers over a rolling 14-day window. The score reflects how strongly tracked creators are currently bullish or bearish on NVO, weighted by each channel's reliability.
Why analysts are watching it
Analysts are closely watching Novo Nordisk (NVO) due to its massive success with the launch of its oral GLP-1 pill, with The Patient Investor stating on June 16, 2026, in "Novo Nordisk Stock Is Nearing An Inflection Point!" that NVO is "killing Lilly in terms of the oral GLP 1 pill launch." This success, combined with the new CEO doing "really, really well," as The Patient Investor mentioned on May 7, 2026, in "PayPal Stock Analysis: The Comeback Is Near!", paints a positive picture. The potential for the company to develop semaglutide into a drug for "aging, protecting organs, or anything" could lead to a "massive, massive move on the stock," according to The Patient Investor on June 16, 2026. Furthermore, partnerships, such as with Hims & Hers, are generating significant interest; on May 12, 2026, Travis Hoium of Asymmetric Investing highlighted that Hims & Hers "fulfilled more than 125,000 shipments for WGO products" within six weeks of introducing direct access to NVO GLP-1 products. However, investors should be aware that NVO has been losing significant market share to Lilly in obesity care, as noted by The Patient Investor on June 16, 2026.
Contributing creators
Source clips
"So you've seen their partnership with Novo Nordisk. That is not a coincidence."
— Hims & Hers Stock: Why This Is a 10x Stock
"you had a massive, massive success in the launch of the NVO pill."
— Novo Nordisk Stock Is Nearing An Inflection Point!
"my opinion on NVO. Looks pretty good to me as a risk to reward bet."
— Novo Nordisk Stock Is Nearing An Inflection Point!
"If NVO could do anything with semaglutide to come up with some kind of a drug for aging, protecting organs, or anything, I would expect a massive massive move on the stock."
— Novo Nordisk Stock Is Nearing An Inflection Point!
"NVO is killing Lilly in terms of the oral GLP 1 pill launch."
— Novo Nordisk Stock Is Nearing An Inflection Point!
"So, in the United States, NVO was charging 1,200, 1,300, 1,500 dollars for those injectable Wegovys. Now, they took it down to like 300."
— Novo Nordisk Stock Is Nearing An Inflection Point!
"Now, to be fair, NVO has been losing massive market share to Lilly in obesity care."
— Novo Nordisk Stock Is Nearing An Inflection Point!
"There's a massive call option on NVO, which I haven't talked about before and I didn't even know it existed. But the CEO talked about it recently. It's very very interesting to me."
— Novo Nordisk Stock Is Nearing An Inflection Point!
"Many of you have asked me for an update on NVO stock."
— Novo Nordisk Stock Is Nearing An Inflection Point!
"Within 6 weeks of introducing direct access to Novo Norris GLP1 products on our platform, we have fulfilled more than 125,000 shipments for WGO products."
— HUGE Hims & Hers Stock News Today! $HIMS
"WGOI and Ozempic. WGOI is going to be the biggest thing there."
— HUGE Hims & Hers Stock News Today! $HIMS
"But, Hims stopped doing it for them to partner up with NVO, which has removed the regulatory risks on the stock, and it has removed the risk of them being sued, and this is a a massive, massive improvement."
— HIMS STOCK IS CRASHING! Here's Why:
"in the second quarter you'd start to transition to the Novo Nordisk to that Nova Nordisk partnership that was announced that's going to potentially have tailwinds for both of these numbers."
— BREAKING: Hims & Hers Earnings Breakdown | The Growth Nobody's Talking About
"This is what's happening with NVO. The new CEO is doing really, really well."
— PayPal Stock Analysis: The Comeback Is Near!
Frequently asked about NVO
Is NVO a buy according to finance YouTubers?
Tracked finance YouTubers are currently bullish on NVO (Novo Nordisk A/S), giving it a reliability-weighted signal score of 62/100 on StockMarketSignals. This reflects creator sentiment over a rolling 14-day window and is not investment advice.
What is NVO's reliability score?
NVO has a StockMarketSignals reliability score of 62/100, based on 3 finance YouTubers. Scores above 60 indicate net-bullish creator sentiment, while scores below 40 indicate net-bearish sentiment.
Which finance YouTubers cover NVO?
NVO has been covered by Couch Investor, Asymmetric Investing by Travis Hoium, The Patient Investor on StockMarketSignals. Each creator is weighted by a reliability score based on the historical accuracy of their past calls.
How is the NVO signal calculated?
The NVO signal aggregates every tracked YouTuber mention, weighting each by the creator's reliability and decaying older mentions over a 90-day window. Bullish mentions push the score above 50, bearish mentions below it.